1 6 5
S E P T E M B E R 2 0 1 5 | O U T P AT I E N T S U R G E R Y M A G A Z I N E O N L I N E
Implantable Miniature Telescope for AMD Patients
The Implantable Miniature Telescope is the only FDA-approved surgical device for
end-stage AMD, the most advanced form of macular degeneration. Smaller than a
pea, the telescope is implanted in one eye. In the implanted eye, the device renders
enlarged central vision images over a wide area of the retina to improve central
vision, while the non-operated eye provides peripheral vision for mobility and ori-
entation. The implant is indicated for patients 65 and up with stable severe to pro-
found vision impairment (best-corrected distance visual acuity 20/160 to 20/800)
caused by bilateral central scotomas associated with end-stage AMD. CMS reimburs-
es the telescope under a revised Ambulatory Payment Classification designation,
APC 0351, Level V Intraocular Procedures. Medicare reimbursement is $23,075.30
for hospitals and $22,674.60 for surgical centers.
centrasight.com